These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33789940)

  • 1. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
    Huang SY; Kung YA; Huang PN; Chang SY; Gong YN; Han YJ; Chiang HJ; Liu KT; Lee KM; Chang CY; Chang CC; Huang CG; Shih SR
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spike mutation D614G alters SARS-CoV-2 fitness.
    Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
    Nature; 2021 Apr; 592(7852):116-121. PubMed ID: 33106671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
    Zhang L; Jackson CB; Mou H; Ojha A; Peng H; Quinlan BD; Rangarajan ES; Pan A; Vanderheiden A; Suthar MS; Li W; Izard T; Rader C; Farzan M; Choe H
    Nat Commun; 2020 Nov; 11(1):6013. PubMed ID: 33243994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
    Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
    Elife; 2021 Feb; 10():. PubMed ID: 33570490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
    Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT
    Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Benton DJ; Wrobel AG; Roustan C; Borg A; Xu P; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33579792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE.
    Juma KM; Morimoto K; Sharma V; Sharma K; Biyani R; Biyani M; Takita T; Yasukawa K
    Mol Biol Rep; 2024 Feb; 51(1):289. PubMed ID: 38329653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
    Jackson CB; Zhang L; Farzan M; Choe H
    Biochem Biophys Res Commun; 2021 Jan; 538():108-115. PubMed ID: 33220921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020.
    Leung K; Pei Y; Leung GM; Lam TT; Wu JT
    Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.
    Shi PY; Plante J; Liu Y; Liu J; Xia H; Johnson B; Lokugamage K; Zhang X; Muruato A; Zou J; Fontes-Garfias C; Mirchandani D; Scharton D; Kalveram B; Bilello J; Ku Z; An Z; Freiberg A; Menachery V; Xie X; Plante K; Weaver S
    Res Sq; 2020 Sep; ():. PubMed ID: 32935091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.
    Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
    bioRxiv; 2020 Sep; ():. PubMed ID: 32908978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity.
    Zhang L; Jackson CB; Mou H; Ojha A; Rangarajan ES; Izard T; Farzan M; Choe H
    bioRxiv; 2020 Jun; ():. PubMed ID: 32587973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
    Weissman D; Alameh MG; de Silva T; Collini P; Hornsby H; Brown R; LaBranche CC; Edwards RJ; Sutherland L; Santra S; Mansouri K; Gobeil S; McDanal C; Pardi N; Hengartner N; Lin PJC; Tam Y; Shaw PA; Lewis MG; Boesler C; Şahin U; Acharya P; Haynes BF; Korber B; Montefiori DC
    Cell Host Microbe; 2021 Jan; 29(1):23-31.e4. PubMed ID: 33306985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
    Korber B; Fischer WM; Gnanakaran S; Yoon H; Theiler J; Abfalterer W; Hengartner N; Giorgi EE; Bhattacharya T; Foley B; Hastie KM; Parker MD; Partridge DG; Evans CM; Freeman TM; de Silva TI; ; McDanal C; Perez LG; Tang H; Moon-Walker A; Whelan SP; LaBranche CC; Saphire EO; Montefiori DC
    Cell; 2020 Aug; 182(4):812-827.e19. PubMed ID: 32697968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.
    Lee CY; Amrun SN; Chee RS; Goh YS; Mak TM; Octavia S; Yeo NK; Chang ZW; Tay MZ; Torres-Ruesta A; Carissimo G; Poh CM; Fong SW; Bei W; Lee S; Young BE; Tan SY; Leo YS; Lye DC; Lin RT; Maurer-Stroh S; Lee B; Wang CI; Renia L; Ng LF
    Clin Transl Immunology; 2021; 10(2):e1241. PubMed ID: 33628442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary dynamics of SARS-CoV-2 circulating in Yogyakarta and Central Java, Indonesia: sequence analysis covering furin cleavage site (FCS) region of the spike protein.
    Wijayanti N; Gazali FM; Supriyati E; Hakim MS; Arguni E; Daniwijaya MEW; Nuryastuti T; Nuhamunada M; Nabilla R; Haryana SM; Wibawa T
    Int Microbiol; 2022 Aug; 25(3):531-540. PubMed ID: 35165816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.